Share This

Related Topics News -

     
 Title only   |   Print 
     
《大行》交銀國際對醫藥股投資評級及目標價(表)

2025-06-23T  
科倫博泰生物藥物佳泰萊獲授予突破性療法認定

2025-06-11T  
《大行》交銀國際:醫藥板塊擁多重利好 趨勢穩中向好

2025-06-05T  
科倫博泰生物擬折讓7.6%配股 淨籌19.4億元

2025-06-05T  
《大行》交銀國際:美臨床腫瘤學會大會上多項國產創新藥重磅數據公布 中國創新藥入選數量創新高

2025-05-29T  
科倫博泰生物將於美國ASCO年會上公布六項臨床研究成果

2025-05-23T  
科倫博泰生物蘆康沙妥珠單抗新增適應症上市申請獲內地受理

2025-05-22T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.